139 related articles for article (PubMed ID: 17594923)
1. Antifungal susceptibility of Candida species using the Clinical and Laboratory Standards Institute disk diffusion and broth microdilution methods.
Noake T; Kuriyama T; White PL; Potts AJ; Lewis MA; Williams DW; Barnes RA
J Chemother; 2007 Jun; 19(3):283-7. PubMed ID: 17594923
[TBL] [Abstract][Full Text] [Related]
2. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Lee SC; Lo HJ; Fung CP; Lee N; See LC
J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints].
Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398
[TBL] [Abstract][Full Text] [Related]
4. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
Espinel-Ingroff A; Canton E; Gibbs D; Wang A
J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
[TBL] [Abstract][Full Text] [Related]
6. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.
Matar MJ; Ostrosky-Zeichner L; Paetznick VL; Rodriguez JR; Chen E; Rex JH
Antimicrob Agents Chemother; 2003 May; 47(5):1647-51. PubMed ID: 12709335
[TBL] [Abstract][Full Text] [Related]
7. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Sep; 65(1):27-34. PubMed ID: 19679232
[TBL] [Abstract][Full Text] [Related]
8. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
[TBL] [Abstract][Full Text] [Related]
10. Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole.
Ozkutuk A; Ergon C; Metin DY; Yucesoy M; Polat SH
J Chemother; 2008 Feb; 20(1):87-92. PubMed ID: 18343749
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin, Italy.
Mandras N; Tullio V; Allizond V; Scalas D; Banche G; Roana J; Robbiano F; Fucale G; Malabaila A; Cuffini AM; Carlone N
Antimicrob Agents Chemother; 2009 Apr; 53(4):1657-9. PubMed ID: 19188375
[TBL] [Abstract][Full Text] [Related]
12. Regression analysis and categorical agreement of fluconazole disk zone diameters and minimum inhibitory concentration by broth microdilution of clinical isolates of Candida.
Aggarwal P; Kashyap B
J Mycol Med; 2017 Jun; 27(2):220-226. PubMed ID: 28363817
[TBL] [Abstract][Full Text] [Related]
13. Are disk diffusion and Etest methods reliable for detecting Candida glabrata and other species' susceptibility to fluconazole and voriconazole?
Kiraz N; Oz Y; Dag I
J Chemother; 2010 Aug; 22(4):280-2. PubMed ID: 20685635
[No Abstract] [Full Text] [Related]
14. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Rinaldi MG; Barnes R; Hu B; Veselov AV; Tiraboschi N; Nagy E; Gibbs DL
J Clin Microbiol; 2005 Dec; 43(12):5848-59. PubMed ID: 16333066
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolates.
Rementeria A; Sanchez-Vargas LO; Villar M; Casals JB; Carrillo-Munoz AJ; Rodriguez Andres C; Eraso E; Quindos G
J Chemother; 2007 Apr; 19(2):172-7. PubMed ID: 17434826
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
Kronvall G; Karlsson I
J Clin Microbiol; 2001 Apr; 39(4):1422-8. PubMed ID: 11283066
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the VITEK 2 system (AST-YSO1 cards) for antifungal susceptibility testing against different Candida species].
Ochiuzzi ME; Arechavala A; Guelfand L; Maldonado I; Soloaga R;
Rev Argent Microbiol; 2014; 46(2):111-8. PubMed ID: 25011594
[TBL] [Abstract][Full Text] [Related]
18. Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
Méndez CC; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E
Med Mycol; 2008 Mar; 46(2):119-23. PubMed ID: 18324490
[TBL] [Abstract][Full Text] [Related]
19. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
Buchta V; Vejsova M; Vale-Silva LA
Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162
[TBL] [Abstract][Full Text] [Related]
20. [Disk diffusion method for fluconazole susceptibility testing of Candida spp. isolates].
Rodero L; Córdoba S; Vivot W; Campo M; Corfield P; Olguín C; Cuirolo A; Soria M; Guelfand L; Canteros CE; Davel G;
Rev Argent Microbiol; 2006; 38(3):155-63. PubMed ID: 17152217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]